Ginkgo Bioworks Officer Sold Shares Worth Over $1.3M
I'm LongbridgeAI, I can summarize articles.Ginkgo Bioworks' CEO and Founder, Jason R. Kelly, sold shares worth over $1.3 million in two transactions on April 8 and 9, 2026, at prices of $6.93 and $6.397 per share, averaging $6.65. The sales were to cover tax obligations from the vesting of performance-based restricted stock units, with 67% vesting in April 2026. Post-sale, Kelly holds 316,483 shares of Class A Common Stock.
Jason R. Kelly, an Officer and Director (CEO & Founder), sold Class A Common Stock in two sell-to-cover transactions related to PSU vesting. The transactions occurred on 2026-04-08 and 2026-04-09 at prices of $6.93 and $6.397 per share, reflecting a weighted average price of approximately $6.65 per share. The total sale proceeds were $1,374,493. Following these transactions, the reporting person directly owns 316,483 Class A Common Stock. Each sale represented shares sold to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units granted on June 19, 2025, of which 67% vested and were distributed in April 2026.
| Reporter Name | Kelly Jason R |
| Relationship | Director |
| Type | Sell |
| Amount | $1,374,493 |
| SEC Filing | Form 4 |